Biocryst Pharmaceuticals (BCRX) Long-Term Debt Repayments (2018 - 2026)
Biocryst Pharmaceuticals (BCRX) recorded Long-Term Debt Repayments of $361,000 in Q2 2026, down 99.5% from $68.99 million a year earlier but up 4.6% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Long-Term Debt Repayments (2018 - 2026) Analysis & Trends
On a TTM basis, Biocryst Pharmaceuticals' Long-Term Debt Repayments came in at $231.2 million as of Jun 30, 2026, up 228.3% year-over-year; for FY2025, it came in at $300 million.
- Across earlier years, Long-Term Debt Repayments came in at $1.7 million in FY2024 (-99.3%) and $240.45 million in FY2023.
- Quarterly Long-Term Debt Repayments has ranged from $345,000 in Q1 2026 to $240.45 million in Q2 2023 over the past five years.
- Per Business Quant, the preceding three quarters came in at $345,000 (Q1 2026), $184.15 million (Q4 2025) and $46.34 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 873.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.00 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 5.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 20.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 2.46 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 17.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Biocryst Pharmaceuticals | 1.98 Bn | 897.45 Mn | 214.41 Mn | 361,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 361,000.00 |
| Mar 31, 2026 | 345,000.00 |
| Dec 31, 2025 | 184.58 Mn |
| Sep 30, 2025 | 46.85 Mn |
| Jun 30, 2025 | 70.04 Mn |
| Mar 31, 2025 | 516,000.00 |
| Dec 31, 2024 | 356,000.00 |
| Sep 30, 2024 | 556,000.00 |
| Jun 30, 2024 | 402,000.00 |
| Mar 31, 2024 | 390,000.00 |
| Dec 31, 2023 | 1.17 Mn |
| Jun 30, 2023 | 240.45 Mn |
| Jun 30, 2018 | 1.73 Mn |
| Mar 31, 2018 | 1.73 Mn |
API Access
Biocryst Pharmaceuticals Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();